Viewing Study NCT00147056



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00147056
Status: UNKNOWN
Last Update Posted: 2021-09-08
First Post: 2005-09-02

Brief Title: MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
Sponsor: InSightec
Organization: InSightec

Study Overview

Official Title: A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors
Status: UNKNOWN
Status Verified Date: 2021-08
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the safety of MRI-guided focused ultrasound thermal ablation of brain tumors performed through intact human skull using the ExAblate transcranial system We will collect data to establish the basic safety of this type of treatment as the basis for later studies that will evaluate its clinical efficacy
Detailed Description: In this non-randomized feasibility study FUS under MRI-guidance and thermometry will be given through intact human skull to brain tumor in up to ten 10 subjects These subjects will be followed over a 3-month period with contrast MRI and clinical exams

The objectives are

1 To evaluate the safety of ExAblate TcMRgFUS treatment delivered through intact human skull to the brain during the treatment and during the follow-up period of 3 months
2 To evaluate the effect of thermal ablation in the target tumor with contrast MR imaging to identify viable tumor and non-viable thermally ablated tissue

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None